{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:48:39Z","timestamp":1786981719004,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009399","name":"Peking University Third Hospital","doi-asserted-by":"publisher","award":["BYSY2018024"],"award-info":[{"award-number":["BYSY2018024"]}],"id":[{"id":"10.13039\/501100009399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81873619"],"award-info":[{"award-number":["Grant No. 81873619"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81570663"],"award-info":[{"award-number":["Grant No. 81570663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-03986-x","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T13:01:51Z","timestamp":1710594111000},"page":"2695-2703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients"],"prefix":"10.1007","volume":"56","author":[{"given":"Shu-Hong","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La-Ta","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"issue":"4","key":"3986_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","volume":"58","author":"MJ Budoff","year":"2011","unstructured":"Budoff MJ, Rader DJ, Reilly MP, Mohler ER III, Lash J, Yang W, Rosen L, Glenn M, Teal V, Feldman HI, CRIC Study Investigators (2011) Relationship of estimated GFR and coronary artery calcification in the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis 58(4):519\u2013526","journal-title":"Am J Kidney Dis"},{"key":"3986_CR2","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/ijms21082685","volume":"21","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Lee I-K, Jeon J-H (2020) Vascular calcification\u2014new insights into its mechanism. Int J Mol Sci 21:2685","journal-title":"Int J Mol Sci"},{"key":"3986_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.carpath.2017.01.004","volume":"27","author":"K Benz","year":"2017","unstructured":"Benz K, Varga I, Neureiter D, Campean V, Daniel C, Heim C, Reimann A, Weyand M, Hilgers KF, Amann K (2017) Vascular inflammation and media calcification are already present in early stages of chronic kidney disease. Cardiovasc Pathol 27:57\u201367","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"3986_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1744-9987.2012.01141.x","volume":"17","author":"GU Okyay","year":"2013","unstructured":"Okyay GU, Er RE, Tekbudak MY, Pa\u015fao\u011flu \u00d6, Inal S, \u00d6ne\u00e7 K, Pa\u015fao\u011flu H, Altok K, Derici \u00dc, Erten Y (2013) Novel inflammatory marker in dialysis patients. Ther Apher Dial 17(2):193\u2013201","journal-title":"Ther Apher Dial"},{"issue":"4","key":"3986_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1354750X.2018.1428359","volume":"23","author":"TL Nielsen","year":"2018","unstructured":"Nielsen TL, Plesner LL, Warming PE, Pallisgaard JL, Dalsgaard M, Schou M, H\u00f8st U, Rydahl C, Brandi L, K\u00f8ber L, Johansen JS, Kastrup J, Iversen KK (2018) YKL-40 in patients with end-stage renal disease receiving haemodialysis. Biomarkers 23(4):357\u2013363","journal-title":"Biomarkers"},{"issue":"2","key":"3986_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/ckj\/sfz056","volume":"13","author":"A Vega","year":"2019","unstructured":"Vega A, Sanchez-Ni\u00f1o MD, Ortiz A, Abad S, Mac\u00edas N, Aragoncillo I, Sants A, Garc\u00eda-Prieto A, Torres E, Hern\u00e1ndez A, S\u00e1nchez-C\u00e1mara L, Hurtado E, Vali\u00f1o-Rivas L, Lu\u00f1o J (2019) The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis pa -tients. Clin Kidney J 13(2):172\u2013178","journal-title":"Clin Kidney J"},{"issue":"6","key":"3986_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5414\/CN111163","volume":"100","author":"SH Bi","year":"2023","unstructured":"Bi SH, Su C, Yang P, Zhang X, Wang Y, Tang W, Yang W, He L (2023) Higher serum trimethylamine N-oxide (TMAO) levels are associated with increased visceral fat in hemodialysis patients. Clin Nephrol 100(6):275\u2013283","journal-title":"Clin Nephrol"},{"issue":"2","key":"3986_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0021-9150(97)00106-8","volume":"132","author":"LI Kauppila","year":"1997","unstructured":"Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132(2):245\u2013250","journal-title":"Atherosclerosis"},{"issue":"1","key":"3986_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40620-015-0260-7","volume":"30","author":"MJ Peeters","year":"2017","unstructured":"Peeters MJ, van den Brand JA, van Zuilen AD, Koster Y, Bots ML, Vervloet MG, Blankestijn PJ, Wetzels JF, MASTERPLAN Study Group (2017) Abdominal aortic calcification in patients with CKD. J Nephrol 30(1):109\u2013118","journal-title":"J Nephrol"},{"issue":"1","key":"3986_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1080\/0886022X.2021.2003205","volume":"43","author":"SJ Zhou","year":"2021","unstructured":"Zhou SJ, Wang XX, Shi JB, Han QF, He L, Tang W, Zhang AH (2021) Serum fatty acid binding protein 4 levels are associated with abdominal aortic calcification in peritoneal dialysis patients. Ren Fail 43(1):1539\u20131548","journal-title":"Ren Fail"},{"key":"3986_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.kint.2017.07.010","volume":"93","author":"G Lorenz","year":"2018","unstructured":"Lorenz G, Schmalenberg M, Kemmner S, Haller B, Steubl D, Pham D, Schreiegg A, Bachmann Q, Schmidt A, Haderer S, Huber M, Angermann S, G\u00fcnt-hner R, Braunisch M, Hauser C, Reichelt AL, Matschkal J, Suttmann Y, Moo-g P, Stock K, K\u00fcchle C, Th\u00fcrmel K, Renders L, Bauer A, Baumann M, He-emann U, Luppa PB, Schmaderer C (2018) Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40 kDa glycoprotein associated with inflammation. Kidney Int 93:221\u2013230","journal-title":"Kidney Int"},{"issue":"9\u201310","key":"3986_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","volume":"412","author":"SE Bojesen","year":"2011","unstructured":"Bojesen SE, Johansen JS, Nordestgaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412(9\u201310):709\u2013712","journal-title":"Clin Chim Acta"},{"key":"3986_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cyto.2013.02.014","volume":"62","author":"K Pawlak","year":"2013","unstructured":"Pawlak K, Rozkiewicz D, Mysliwiec M, Pawlak D (2013) YKL-40 in hemodialyzed patients with and without cardiovascular complications\u2013the enhancement by the coexistence of the seropositivity against hepatitis C virus infection. Cytokine 62:75\u201380","journal-title":"Cytokine"},{"key":"3986_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cyto.2011.03.014","volume":"55","author":"AR Nielsen","year":"2011","unstructured":"Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK (2011) IL-6, but not TNF-a, increases plasma YKL-40 in human subjects. Cytokine 55:152\u2013155","journal-title":"Cytokine"},{"key":"3986_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/00365520310000537","volume":"38","author":"I Vind","year":"2003","unstructured":"Vind I, Johansen JS, Price PA, Munkholm P (2003) SerumYKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 38:599\u2013605","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"3986_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006643","volume":"13","author":"F Arain","year":"2020","unstructured":"Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T (2020) YKL-40 (chitinase-3-Like Protein 1) serum levels in aortic stenosis. Circ Heart Fail 13(10):e006643","journal-title":"Circ Heart Fail"},{"key":"3986_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.02.035","volume":"211","author":"AE Michelsen","year":"2010","unstructured":"Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-S\u00f8rensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589\u2013595","journal-title":"Atherosclerosis"},{"key":"3986_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCGENETICS.108.820795","volume":"2","author":"Y Boss\u00e9","year":"2009","unstructured":"Boss\u00e9 Y, Miqdad A, Fournier D, P\u00e9pin A, Pibarot P, Mathieu P (2009) Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves. Circ Cardiovasc Genet 2:489\u2013498","journal-title":"Circ Cardiovasc Genet"},{"key":"3986_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.kint.2017.08.009","volume":"93","author":"F Persson","year":"2018","unstructured":"Persson F, Borg R (2018) YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology. Kidney Int 93:21\u201322","journal-title":"Kidney Int"},{"key":"3986_CR20","first-page":"351","volume":"110","author":"B Volck","year":"1998","unstructured":"Volck B, Price PA, Johansen JS (1998) YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 110:351\u2013360","journal-title":"Proc Assoc Am Physicians"},{"key":"3986_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2261-12-35","volume":"12","author":"WH Ma","year":"2012","unstructured":"Ma WH, Wang XL, Du YM, Wang YB, Zhang Y, Wei DE, Guo LL, Bu PL (2012) Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovasc Disord 12:35","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"3986_CR22","first-page":"172","volume":"53","author":"JS Johansen","year":"2006","unstructured":"Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53(2):172\u2013209","journal-title":"Dan Med Bull"},{"key":"3986_CR23","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cellsig.2013.03.016","volume":"25","author":"M Prakash","year":"2013","unstructured":"Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, Eriksson C (2013) Diverse pathological implications of YKL-40: answers may lie in \u201coutside-in\u201d signaling. Cell Signal 25:1567\u20131573","journal-title":"Cell Signal"},{"issue":"2","key":"3986_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5527\/wjn.v1.i2.43","volume":"1","author":"S Disthabanchong","year":"2012","unstructured":"Disthabanchong S (2012) Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol 1(2):43\u201353","journal-title":"World J Nephrol"},{"key":"3986_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","volume":"55","author":"CN Rathcke","year":"2006","unstructured":"Rathcke CN, Vestergaard H (2006) YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55:221\u2013227","journal-title":"Inflamm Res"},{"key":"3986_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2337\/dc08-1144","volume":"32","author":"CN Rathcke","year":"2009","unstructured":"Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H (2009) YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323\u2013328","journal-title":"Diabetes Care"},{"key":"3986_CR27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.metabol.2011.09.004","volume":"61","author":"I Kyrgios","year":"2012","unstructured":"Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, Haidich AB (2012) Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 61:562\u2013568","journal-title":"Metabolism"},{"key":"3986_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141730","volume":"10","author":"E \u017burawska-P\u0142aksej","year":"2015","unstructured":"\u017burawska-P\u0142aksej E, \u0141ugowska A, Hetma\u0144czyk K, Knapik-Kordecka M, Piwowar A (2015) Neutrophils as a source of chitinases and chitinase-like proteins in type 2 diabetes. PLoS ONE 10:e0141730","journal-title":"PLoS ONE"},{"issue":"11","key":"3986_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/diagnostics10110909","volume":"10","author":"GV Kapoula","year":"2020","unstructured":"Kapoula GV, Kontou PI, Bagos PG (2020) Diagnostic performance of biomarkers urinary KIM-1 and YKL-40 for early diabetic nephropathy, in patients with type 2 diabetes: a systematic review and meta-analysis. Diagnostics (Basel) 10(11):909","journal-title":"Diagnostics (Basel)"},{"key":"3986_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1681\/ASN.2020040487","volume":"32","author":"SJ Schrauben","year":"2021","unstructured":"Schrauben SJ, Shou H, Zhang X, Anderson AH, Bonventre JV, Chen J, Coca S, Furth SL, Greenberg JH, Gutierrez OM, Ix JH, Lash JP, Parikh CR, Rebholz CM, Sabbisetti V, Sarnak MJ, Shlipak MG, Waikar SS, Kimmel PL, Vasan RS, Feldman HI, Schelling JR, CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators (2021) Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol 32:115\u2013126","journal-title":"J Am Soc Nephrol"},{"key":"3986_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.ajkd.2018.07.016","volume":"73","author":"GN Nadkarni","year":"2019","unstructured":"Nadkarni GN, Chauhan K, Rao V, Ix JH, Shlipak MG, Parikh CR, Coca SG (2019) Effect of intensive blood pressure lowering on kidney tubule injury: findings from the ACCORD trial study participants. Am J Kidney Dis 73:31\u201338","journal-title":"Am J Kidney Dis"},{"key":"3986_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/1354750X.2014.992475","volume":"20","author":"E \u017burawska-P\u0142aksej","year":"2015","unstructured":"\u017burawska-P\u0142aksej E, \u0141ugowska A, Hetma\u0144czyk K, Knapik-Kordecka M, Adamiec R, Piwowar A (2015) Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2. Biomarkers 20:52\u201357","journal-title":"Biomarkers"},{"issue":"5","key":"3986_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000444855","volume":"83","author":"MD Rosa","year":"2016","unstructured":"Rosa MD, Malaguarnera L (2016) Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications. Pathobiology 83(5):228\u2013242","journal-title":"Pathobiology"},{"key":"3986_CR34","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1086\/315050","volume":"180","author":"C Nordenbaek","year":"1999","unstructured":"Nordenbaek C, Johansen JS, Junker P, Borregaard N, S\u00f8rensen O, Price PA (1999) YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 180:1722\u20131726","journal-title":"J Infect Dis"},{"issue":"8","key":"3986_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043498","volume":"7","author":"CN Rathcke","year":"2012","unstructured":"Rathcke CN, Thomsen SB, Linneberg A, Vestergaard H (2012) Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke. PLoS ONE 7(8):e43498","journal-title":"PLoS ONE"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-03986-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03986-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T23:37:26Z","timestamp":1721777846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-03986-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3986"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-03986-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,16]]},"assertion":[{"value":"16 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. All participants have given written informed consent and the study protocol has been approved by the Ethics Committee of Peking University Third Hospital (IRB 00006761).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}